Paul J. Hanson

Paul J. Hanson

Auto-generated profile, based on publicly available information

Paul J. Hanson

UBC Centre for Heart Lung Innovation, Vancouver, BC, Canada.

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2021 in Science Translational Medicine
Verified
Journal Article
Open access
PDF file
JPJuan A. Perez-Bermejo
Juan A. Perez-Bermejo
SKSerah Kang
Serah Kang
SRSarah J. Rockwood
Sarah J. Rockwood
CSCamille R. Simoneau
Camille R. Simoneau
DJDavid A. Joy
David A. Joy
TMTodd C. McDevitt
Todd C. McDevitt
Infection of human iPSC–derived cardiomyocytes by SARS-CoV-2 leads to specific cytopathic features reflected in patient autopsy samples.

5 February 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AGAinoosh Golpour
Ainoosh Golpour
DPDimitri Patriki
Dimitri Patriki
PHPaul J. Hanson
Paul J. Hanson
BMBruce McManus
Bruce McManus
BHBettina Heidecker
Bettina Heidecker
Myocarditis is an inflammatory disease of the heart muscle with a wide range of potential etiological factors and consequently varying clinical patterns across the world. In this review, we address the epidemiology of myocarditis. Myocarditis was considered a rare disease until intensified research efforts in recent decades revealed its true epidemiological importance. While it remains a challenge to determine the true prevalence of myocarditis, studies are underway to obtain better approximations of the proportions of this disease. Nowadays, the prevalence of myocarditis has been reported from 10.2 to 105.6 per 100,000 worldwide, and its annual occurrence is estimated at about 1.8 million cases. This wide range of reported cases reflects the uncertainty surrounding the true prevalence and a potential underdiagnosis of this disease. Since myocarditis continues to be a significant public health issue, particularly in young adults in whom myocarditis is among the most common causes of sudden cardiac death, improved diagnostic and therapeutic procedures are necessary. This manuscript aims to summarize the current knowledge on the epidemiology of myocarditis, new diagnostic approaches and the current epidemiological impact of the COVID-19 pandemic.

4 January 2023 in Laboratory Investigation
Verified
Journal Article
Closed access
PHPaul J. Hanson
Paul J. Hanson
FLFelicia Liu-Fei
Felicia Liu-Fei
CNCoco Ng
Coco Ng
TMTaylor A. Minato
Taylor A. Minato
CLChi Lai
Chi Lai
BMBruce M. McManus
Bruce M. McManus

1 January 2012 in Frontiers in Microbiology
Verified
Journal Article
Open access
PHPaul J. Hanson
Paul J. Hanson
HZHuifang M. Zhang
Huifang M. Zhang
MHMaged Hemida
Maged Hemida
XYXin Ye
Xin Ye
YQYe Qiu
Ye Qiu
DYDecheng Yang
Decheng Yang
Many virus infections and stresses can induce endoplasmic reticulum (ER) stress response, a host self-defense mechanism against viral invasion and stress. During this event, viral and cellular gene expression is actively regulated and often encounters a switching of the translation initiation from cap-dependent to internal ribosome-entry sites (IRES)-dependent. This switching is largely dependent on the mRNA structure of the 5′ untranslated region (5′ UTR) and on the particular stress stimuli. Picornaviruses and some other viruses contain IRESs within their 5′ UTR of viral genome and employ an IRES-driven mechanism for translation initiation. Recently, a growing number of cellular genes involved in growth control, cell cycle progression and apoptosis were also found to contain one or more IRES within their long highly structured 5′ UTRs. These genes initiate translation usually by a cap-dependent mechanism under normal physiological conditions; however, in certain environments, such as infection, starvation, and heat shock they shift translation initiation to an IRES-dependent modality. Although the molecular mechanism is not entirely understood, a number of studies have revealed that several cellular biochemical processes are responsible for the switching of translation initiation to IRES-dependent. These include the cleavage of translation initiation factors by viral and/or host proteases, phosphorylation (inactivation) of host factors for translation initiation, overproduction of homologous proteins of cap-binding protein eukaryotic initiation factors (eIF)4E, suppression of cap-binding protein eIF4E expression by specific microRNA, activation of enzymes for mRNA decapping, as well as others. Here, we summarize the recent advances in our understanding of the molecular mechanisms for the switching of translation initiation, particularly for the proteins involved in cell survival and apoptosis in the ER stress pathways during viral infections.

1 January 2022 in Laboratory Investigation
Verified
Journal Article
Closed access
PDF file
PHPaul J. Hanson
Paul J. Hanson
FLFelicia Liu-Fei
Felicia Liu-Fei
TMTaylor A. Minato
Taylor A. Minato
AHAl Rohet Hossain
Al Rohet Hossain
HRHarpreet Rai
Harpreet Rai
BMBruce M. McManus
Bruce M. McManus

21 March 2021 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
SSSina Safabakhsh
Sina Safabakhsh
PPPankaj Panwar
Pankaj Panwar
SBScott Barichello
Scott Barichello
SSSarabjit S Sangha
Sarabjit S Sangha
PHPaul J Hanson
Paul J Hanson
ZLZachary Laksman
Zachary Laksman
Atrial fibrillation (AF) is the most common arrhythmia worldwide. It is associated with significant increases in morbidity in the form of stroke and heart failure, and a doubling in all-cause mortality. The pathophysiology of AF is incompletely understood, and this has contributed to a lack of effective treatments and disease-modifying therapies. An important cellular process that may explain how risk factors give rise to AF includes post-translational modification of proteins. As the most commonly occurring post-translational modification, protein phosphorylation is especially relevant. Although many methods exist for studying protein phosphorylation, a common and highly resolute technique is mass spectrometry (MS). This review will discuss recent evidence surrounding the role of protein phosphorylation in the pathogenesis of AF. MS-based technology to study phosphorylation and uses of MS in other areas of medicine such as oncology will also be presented. Based on these data, future goals and experiments will be outlined that utilize MS technology to better understand the role of phosphorylation in AF and elucidate its role in AF pathophysiology. This may ultimately allow for the development of more effective AF therapies.